The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment

Pu, Christy; Lan, Virginia M.; Lan, Chia-Ying; Lang, H.

doi:10.1111/j.1365-2354.2007.00865.x

Cited by 41 publications

(35 citation statements)

References 17 publications

(52 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We screened 2879 abstracts from electronic search, and 39 full texts were retrieved for further assessment. With the application of exclusion criteria, 14 papers were considered ineligible . Finally, 25 studies from electronic searches were included.…”

Section: Resultsmentioning

confidence: 99%

Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies

Chung

Lau

et al. 2012

Health Expectations

109

102

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies

Chung

Lau

et al. 2012

Health Expectations

109

102

View full text Add to dashboard Cite

show abstract

“…Thus, TCM has a higher level of accessibility because of less financial barrier. A study on the determinants of TCM and acupuncture utilization of patients with cervical, breast, lung, liver, or colorectal cancers in Taiwan has shown that the prevalence of TCM and acupuncture use for lung cancer patients is 16.03% and 2.53%, respectively [11]. …”

Section: Introductionmentioning

confidence: 99%

Distributions of Usage and the Costs of Conventional Medicine and Traditional Chinese Medicine for Lung Cancer Patients in Taiwan

Liao

Lin

et al. 2013

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Background. This study aims to analyze the utilization patterns of patients with lung cancer stratified by surgery status. Methods. A retrospective cohort study was conducted from 1996 to 2010 by using the Longitudinal Health Insurance Database 2005. Results. Among the 7,677 lung cancer patients, 230 (31.17%) and 1,826 (26.32%) who have and have not undergone surgery have used TCM outpatient services, respectively. For lung cancer patients who have not undergone surgery, patients who are aged 70 years and older, males, occupational members, and farmers and fishermen are less likely to avail of TCM services. For lung cancer patients who have undergone surgery, the likelihood of TCM users is higher in residents who used TCM one year prior to lung cancer diagnosis and in patients with insurance amounts ranging from ≥NT$60,000. The total amount paid per visit for WM is higher than that for one year of TCM outpatient care before and after lung cancer diagnosis. Conclusion. The factors associated with TCM use varied according to surgery status. The costs of insurance covering TCM were consistently lower than those covering WM for lung cancer patients. These findings would be useful for health policy makers who are considering TCM and WM integration.

show abstract

“…Compared with CAM use by Western populations, TCM has a higher level of accessibility due to lesser financial barrier. A study on the determinants of TCM and acupuncture utilization of cancer patients in Taiwan has shown that the prevalence of TCM ranges from 14.81% for cervical cancer to 30.13% for breast cancer [8]. …”

Section: Introductionmentioning

confidence: 99%

Utilization pattern of traditional Chinese medicine for liver cancer patients in Taiwan

Liao

Lin

et al. 2012

BMC Complement Altern Med

View full text Add to dashboard Cite

BackgroundTraditional Chinese Medicine (TCM) is one of the most popular complementary and alternative medicine modalities worldwide. In Chinese and East Asian societies, TCM plays an active role in the modern health care system and is even covered by the National Health Insurance Program of Taiwan. Liver cancer is the second most common cancer in Taiwan. This study aimed to analyze the TCM utilization patterns of patients with liver cancer from 1996–2007 using a population-based random sample of one million insured patients.MethodsA cross-sectional study was conducted using registration and claim data sets from 1996 to 2007 obtained from the Longitudinal Health Insurance Database 2005 (LHID2005). The outpatient datasets contained the encounter form-based dates of visit, three items from the International Classification of Diseases (Ninth Revision, Clinical Modification codes), the primary procedure (e.g., drug or diagnostic procedure), type of copayment, billed amount, and paid amount. Only ambulatory care was analyzed.ResultsA total of 6358 liver cancer patients utilized ambulatory care during the study period. Among them, 1240 (19.50%) availed of TCM outpatient services. The prevalence of TCM use fluctuated during the study period, with a peak of 25.11% in 2001. After multivariable adjustment, the likelihood of TCM users was lower in participants aged 70 years and older (odds ratio, OR = 0.79, 95% confidence interval, CI: 0.64–0.97), males (OR = 0.60, 95% CI: 0.52–0.68), residents of Taipei (OR = 0.75, 95% CI: 0.58–0.96) as well as farmers and fishermen (OR = 0.71, 95% CI: 0.54–0.94), but was higher in residents of central Taiwan (OR = 1.99, 95% CI: 1.56–2.54. Most biomedicine and TCM outpatient services were provided by private clinics, followed by private hospitals. The two most frequently recorded coexisting diseases for both biomedicine and TCM outpatient visits specifically for liver cancer were (1) chronic liver disease and cirrhosis, and (2) malignant neoplasm of the liver and hepatic bile duct. The mean fee per visit for biomedicine was much higher than that for TCM, and the average expenditure was NT$429.73 (US$13.25) per biomedicine visit and NT$301.93 (US$9.32) per TCM visit (US$1 = NT$32.4 in 2007). For outpatient visits specifically for liver cancer, the mean fee per visit for biomedicine was much higher than that for TCM. The average cost per visit was NT$1457.31 (US$44.98) for biomedicine and NT$1080.76 (US$33.36) for TCM.ConclusionTCM was widely used by the patients with liver cancer, and the prevalence of TCM use remained stably high during the study period. The costs of insurance covering TCM were consistently lower than those covering biomedicine in patients with liver cancer. The findings of this study should be useful for health policy makers as well as researchers considering the integration of TCM and biomedicine.

show abstract

The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment

Cited by 41 publications

References 17 publications

Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies

Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies

Distributions of Usage and the Costs of Conventional Medicine and Traditional Chinese Medicine for Lung Cancer Patients in Taiwan

Utilization pattern of traditional Chinese medicine for liver cancer patients in Taiwan

Contact Info

Product

Resources

About